Deployed in contested environments and in the homeland to protect both the warfighter and civilians — identifying bacteria, spores, viruses, and toxins autonomously, for months at a time.

Four main points of application

• Threat detection at the edge: fieldable threat detection for the Department of War
• Building a new biosurveillance program: updating the aging BioWatch program for the Department of Homeland Security
• Critical infrastructure monitoring: monitoring for threats at critical infrastructure, such as courts, airports, and border crossings
• Parcel & mail screening: detection of chem/bio threats in parcels bound for CEOs, judges, and prisoners

Additional applications of interest: pathogen ID in hospital settings, indoor air quality assessment, biomanufacturing quality control, agriculture disease detection.

Real-time identification of infectious disease in individuals — from early, non-invasive detection in hospitalized patients to rapid screening at borders, critical infrastructure, and high-value events, so care and containment decisions can happen before symptoms do.

• Early infection diagnosis and treatment efficacy: early detection of infections such as ventilator-associated pneumonia, a leading cause of sepsis that increases both healthcare costs and patient mortality; can also be deployed to monitor disease progression and to understand treatment needed and optimize antibiotic usage
• Points of entry screening: identification of disease in individuals at points of entry into the U.S., e.g. passengers arriving from countries with a high risk of diseases such as Ebola
• Critical person protection: screening individuals for infection before entry into critical environments such as the Oval Office or No. 10 Downing Street; also relevant in healthcare settings, to monitor the health of employees working with immunocompromised patients